Efficacy and safety of repetitive transcranial magnetic stimulation with different frequencies on neuropathic orofacial pain: a systematic literature review and meta-analysis

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive technique used to treat neuropathic orofacial pain (NOP). This study aimed to evaluate the efficacy and safety of rTMS in managing NOP and reducing health risks. A comprehensive literature search was conducted in various databases, including PubMed, Physiotherapy Evidence Database (PEDro), the Cochrane Library, Web of Science, Embase and Clinical Trials.gov. Thirteen relevant articles were identified and assessed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the Cochrane Risk of Bias assessment tool. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was utilized to evaluate the evidence rating for the studies. The analysis of the thirteen randomized controlled trials, involving 355 eligible patients, demonstrated moderate evidence supporting the significant effect of rTMS in reducing pain intensity (Mean Difference (MD): −1.01, 95% Confidence Interval (CI) −2.39 to −1.48, p < 0.001) and improving the quality of life (QOL) based on various instruments (MD: −9.23, 95% CI −11.91 to −6.54, p < 0.001; MD: −2.1, 95% CI −3.74 to −0.45, p < 0.05). Patients also reported favorable improvements in global impression (MD: −0.54, 95% CI −1.02 to −0.07, p < 0.05) and sensory status (Standardized Mean Difference (SMD): −1.30, 95% CI −1.74 to −0.87, p < 0.001). However, there were no significant improvements in sleep quality (MD: −1.72, 95% CI −4.13 to 0.68, p > 0.05) or psychological status (p > 0.05). Overall, the study demonstrated that rTMS is an effective and safe way to reduce pain, improve QOL, enhance sensory status, and create a positive clinical impression in patients with NOP. Further research is needed to investigate the effects of rTMS on sleep and psychological well-being in individuals with NOP.

Neuropathic orofacial pain; Repetitive transcranial magnetic stimulation; Rehabilitation; Meta-analysis; Neuromodulation

[1] Fehér G, Nemeskéri Z, Pusch G, Zádori I, Bank G, Gurdán Z, et al. Chronic orofacial pain. Hungarian Medical Journal. 2019; 160: 1047–1056. (In Hungarian)

[2] Olesen J. International classification of headache disorders. The Lancet Neurology. 2018; 17: 396–397.

[3] McDonough P, McKenna JP, McCreary C, Downer EJ. Neuropathic orofacial pain: cannabinoids as a therapeutic avenue. The International Journal of Biochemistry & Cell Biology. 2014; 55: 72–78.

[4] Sessle BJ. The societal, political, educational, scientific, and clinical context of orofacial pain. In Sessle BJ (ed). Orofacial pain: recent advances in assessment, management, and understanding of mechanisms (1-25). IASP Press: Washington. 2014.

[5] Shueb SS, Nixdorf DR, John MT, Alonso BF, Durham J. What is the impact of acute and chronic orofacial pain on quality of life? Journal of Dentistry. 2015; 43: 1203–1210.

[6] Renton T, Kahwaja N. Pain part 5a: chronic (neuropathic) orofacial pain. Dental Update. 2015; 42: 744–746, 749–750, 753–754 passim.

[7] Christoforou J. Neuropathic orofacial pain. Dental Clinics of North America. 2018; 62: 565–584.

[8] Toll L, Ozawa A, Cippitelli A. NOP-related mechanisms in pain and analgesia. Handbook of Experimental Pharmacology. 2019; 79: 165–186.

[9] Schütz TCB, Andersen ML, Tufik S. The influence of orofacial pain on sleep pattern: a review of theory, animal models and future directions. Sleep Medicine. 2009; 10: 822–828.

[10] Nasri‐Heir C, Khan J, Heir GM. Topical medications as treatment of neuropathic orofacial pain. Dental Clinics of North America. 2013; 57: 541–553.

[11] Attal N, Poindessous-Jazat F, De Chauvigny E, Quesada C, Mhalla A, Ayache SS, et al. Repetitive transcranial magnetic stimulation for neuropathic pain: a randomized multicentre sham-controlled trial. Brain. 2021; 144: 3328–3339.

[12] Attia M, McCarthy D, Abdelghani M. Repetitive transcranial magnetic stimulation for treating chronic neuropathic pain: a systematic review. Current Pain and Headache Reports. 2021; 25: 48.

[13] Che X, Cash RFH, Luo X, Luo H, Lu X, Xu F, et al. High-frequency rTMS over the dorsolateral prefrontal cortex on chronic and provoked pain: a systematic review and meta-analysis. Brain Stimulation. 2021; 14: 1135–1146.

[14] Luo J, Feng Y, Li M, Yin M, Qin F, Hu X. Repetitive transcranial magnetic stimulation improves neurological function and promotes the anti-inflammatory polarization of microglia in ischemic rats. Frontiers in Cellular Neuroscience. 2022; 16: 878345.

[15] Lefaucheur J, André-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clinical Neurophysiology. 2014; 125: 2150–2206.

[16] Pei Q, Wu B, Tang Y, Yang X, Song L, Wang N, et al. Repetitive transcranial magnetic stimulation at different frequencies for postherpetic neuralgia: a double-blind, sham-controlled, randomized trial. Pain Physician. 2019; 22: E303–E313.

[17] Fricová J, Klírová M, Masopust V, Novák T, Vérebová K, Rokyta R. Repetitive transcranial magnetic stimulation in the treatment of chronic orofacial pain. Physiological Research. 2013; 62: S125–S134.

[18] Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions. The Cochrane Database of Systematic Reviews. 2019; 10: ED000142.

[19] Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. The BMJ. 2019; 366: l4898.

[20] Schwingshackl L, Rüschemeyer G, Meerpohl JJ. How to interpret the certainty of evidence based on GRADE (Grading of Recommendations, Assessment, Development and Evaluation). The Urologist Edition A. 2021; 60: 444–454. (In German)

[21] Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. The BMJ. 2003; 327: 557–560.

[22] Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Research Synthesis Methods. 2010; 1: 97–111.

[23] Liu Z, Xie D, Wen X, Wang R, Yang Q, Liu H, et al. Peripheral repetitive transcranial magnetic stimulation (rTMS) for idiopathic facial nerve palsy: a prospective, randomized controlled trial. Neural Plasticity. 2022; 2022: 7536783.

[24] Andre-Obadia N, Magnin M, Simon E, Garcia-Larrea L. Somatotopic effects of rTMS in neuropathic pain? A comparison between stimulation over hand and face motor areas. European Journal of Pain. 2018; 22: 707–715.

[25] Ayache SS, Ahdab R, Chalah MA, Farhat WH, Mylius V, Goujon C, et al. Analgesic effects of navigated motor cortex rTMS in patients with chronic neuropathic pain. European Journal of Pain. 2016; 20: 1413–1422.

[26] Hosomi K, Shimokawa T, Ikoma K, Nakamura Y, Sugiyama K, Ugawa Y, et al. Daily repetitive transcranial magnetic stimulation of primary motor cortex for neuropathic pain: a randomized, multicenter, double-blind, crossover, sham-controlled trial. Pain. 2013; 154: 1065–1072.

[27] Khedr EM. Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. Journal of Neurology, Neurosurgery & Psychiatry. 2005; 76: 833–838.

[28] Kohútová B, Fricová J, Klírová M, Novák T, Rokyta R. Theta burst stimulation in the treatment of chronic orofacial pain: a randomized controlled trial. Physiological Research. 2017; 66: 1041–1047.

[29] Lefaucheur J. Neurogenic pain relief by repetitive transcranial magnetic cortical stimulation depends on the origin and the site of pain. Journal of Neurology, Neurosurgery & Psychiatry. 2004; 75: 612–616.

[30] Lefaucheur JP, Drouot X, Nguyen JP. Interventional neurophysiology for pain control: duration of pain relief following repetitive transcranial magnetic stimulation of the motor cortex. Neurophysiologie Clinique. 2001; 31: 247–252.

[31] Lindholm P, Lamusuo S, Taiminen T, Pesonen U, Lahti A, Virtanen A, et al. Right secondary somatosensory cortex—a promising novel target for the treatment of drug-resistant neuropathic orofacial pain with repetitive transcranial magnetic stimulation. Pain. 2015; 156: 1276–1283.

[32] Ma S, Ni J, Li X, Yang L, Guo Y, Tang Y. High-frequency repetitive transcranial magnetic stimulation reduces pain in postherpetic neuralgia. Pain Medicine. 2015; 16: 2162–2170.

[33] Umezaki Y, Badran BW, DeVries WH, Moss J, Gonzales T, George MS. The efficacy of daily prefrontal repetitive transcranial magnetic stimulation (rTMS) for burning mouth syndrome (BMS): a randomized controlled single-blind study. Brain Stimulation. 2016; 9: 234–242.

[34] Ferreira NR, Junqueira YN, Corrêa NB, Fonseca EO, Brito NBM, Menezes TA, et al. The efficacy of transcranial direct current stimulation and transcranial magnetic stimulation for chronic orofacial pain: a systematic review. PLOS ONE. 2019; 14: e0221110.

[35] Herrero Babiloni A, Guay S, Nixdorf DR, de Beaumont L, Lavigne G. Non-invasive brain stimulation in chronic orofacial pain: a systematic review. Journal of Pain Research. 2018; 11: 1445–1457.

[36] Sessle BJ. Peripheral and central mechanisms of orofacial inflammatory pain. International Review of Neurobiology. 2011; 60: 179–206.

[37] Hanna J, Shapiro P, Gover-Chamlou A, Komarczyk E. Case report: repetitive transcranial magnetic stimulation for comorbid treatment-resistant depression and trigeminal neuralgia. The Journal of ECT. 2019; 35: e37–e38.

[38] Yang S, Chang MC. Effect of repetitive transcranial magnetic stimulation on pain management: a systematic narrative review. Frontiers in Neurology. 2020; 11: 114.

[39] Hodaj H, Payen JF, Hodaj E, Dumolard A, Maindet C, Cracowski JL, et al. Long-term treatment of chronic orofacial, pudendal, and central neuropathic limb pain with repetitive transcranial magnetic stimulation of the motor cortex. Clinical Neurophysiology. 2020; 131: 1423–1432.

[40] Centorino MB, Bajor LA, Gootam PK, Nakase-Richardson R, Kozel FA. The relationship of transcranial magnetic stimulation with sleep and plasticity. Journal of Psychiatric Practice. 2020; 26: 434–443.

[41] Nardone R, Sebastianelli L, Versace V, Brigo F, Golaszewski S, Pucks-Faes E, et al. Effects of repetitive transcranial magnetic stimulation in subjects with sleep disorders. Sleep Medicine. 2020; 71: 113–121.

[42] Attarian S, Azulay JP, Verschueren A, Pouget J. Magnetic stimulation using a triple-stimulation technique in patients with multifocal neuropathy without conduction block. Muscle & Nerve. 2005; 32: 710–714.